Skip to content
lifestyle.womensconference.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Eton Pharmaceuticals
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
May 21, 2026
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
May 20, 2026
Eton Pharmaceuticals Announces CFO Succession Plan
May 19, 2026
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
February 25, 2026
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
February 9, 2026
←
Previous Page
1
2